Showing results (541-550 of 615) with videos related to
Sort By:
Pageof 62
Clinical and Experimental Gastroenterology|August 9, 2018
Natural orifice specimen extraction in colorectal surgery: patient selection and perspectivesKevin M Izquierdo, Ece Unal, John H MarksClinical and Experimental Gastroenterology|January 8, 2015
Developments in flexible endoscopic surgery: a reviewHubertus Feussner, Valentin Becker, Margit Bauer, et al.Clinical and Experimental Gastroenterology|January 8, 2015
Celiac disease in children: is it a problem in Kuwait?Wafa'a Al-Qabandi, Eman Buhamrah, Dalia Al-Abdulrazzaq, et al.Clinical and Experimental Gastroenterology|November 15, 2014
Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in QatarMoutaz Derbala, Prem Chandra, Aliaa Amer, et al.Clinical and Experimental Gastroenterology|October 14, 2017
Tacrolimus versus anti-tumor necrosis factor agents for steroid-refractory active ulcerative colitis based on the severity of endoscopic findings: a single-center, open-label cohort studySatohiro Matsumoto, Haruna Kawamura, Takeshi Nishikawa, et al.Clinical and Experimental Gastroenterology|October 14, 2017
Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel diseaseHoda M Malaty, Grace Hsiao-Wei Lo, Jason K HouClinical and Experimental Gastroenterology|August 8, 2015
Serum magnesium concentrations in patients receiving sodium picosulfate and magnesium citrate bowel preparation: an assessment of renal function and electrocardiographic conductionGerald Bertiger, Edward Jones, David N Dahdal, et al.Clinical and Experimental Gastroenterology|August 2, 2017
Colorectal endoscopic submucosal dissection: patient selection and special considerationsAndrew Emmanuel, Shraddha Gulati, Margaret Burt, et al.Clinical and Experimental Gastroenterology|August 3, 2017
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infectionTanya M Monaghan, Ola H Negm, Brendon MacKenzie, et al.Clinical and Experimental Gastroenterology|December 18, 2015
Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approachSara Soldi, Sotirios Vasileiadis, Francesca Uggeri, et al.Pageof 62